共 27 条
What Is Clinical Utility and Why Should We Care?
被引:87
作者:

Lesko, L. J.
论文数: 0 引用数: 0
h-index: 0
机构:
US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA

Zineh, I.
论文数: 0 引用数: 0
h-index: 0
机构:
US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA

Huang, S-M
论文数: 0 引用数: 0
h-index: 0
机构:
US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
机构:
[1] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词:
PERSONALIZED MEDICINE;
IMMINENT REALITY;
DRUG DEVELOPMENT;
ELUSIVE DREAM;
D O I:
10.1038/clpt.2010.229
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
引用
收藏
页码:729 / 733
页数:5
相关论文
共 27 条
[1]
Developing Pharmacogenetic Evidence Throughout Clinical Development
[J].
Burns, D. K.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2010, 88 (06)
:867-870

Burns, D. K.
论文数: 0 引用数: 0
h-index: 0
机构:
Duke Univ, Deane Drug Discovery Inst, Durham, NC 27710 USA Duke Univ, Deane Drug Discovery Inst, Durham, NC 27710 USA
[2]
Demonstrating Utility of Pharmacogenetics in Pediatric Populations: Methodological Considerations
[J].
Carleton, B.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2010, 88 (06)
:757-759

Carleton, B.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ British Columbia, Dept Paediat, Div Translat Therapeut, Vancouver, BC, Canada
British Columbia Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC V6H 3V4, Canada
Child & Family Res Inst, Vancouver, BC, Canada Univ British Columbia, Dept Paediat, Div Translat Therapeut, Vancouver, BC, Canada
[3]
Pharmacy Benefit Managers: Evaluating Clinical Utility in the Real World
[J].
Epstein, R. S.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2010, 88 (06)
:880-882

Epstein, R. S.
论文数: 0 引用数: 0
h-index: 0
机构:
Medco Hlth Solut Inc, Franklin Lakes, NJ USA Medco Hlth Solut Inc, Franklin Lakes, NJ USA
[4]
Establishing Clinical Utility of Pharmacogenetic Tests in the Post-FDAAA Era
[J].
Evans, B. J.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2010, 88 (06)
:749-751

Evans, B. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Houston, Ctr Law, Hlth Law & Policy Inst, Houston, TX 77004 USA
Univ Houston, Ctr Law, Ctr Biotechnol & Law, Houston, TX 77004 USA Univ Houston, Ctr Law, Hlth Law & Policy Inst, Houston, TX 77004 USA
[5]
Evaluating the utility of personal genomic information
[J].
Foster, Morris W.
;
Mulvihill, John J.
;
Sharp, Richard R.
.
GENETICS IN MEDICINE,
2009, 11 (08)
:570-574

Foster, Morris W.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA
Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA

Mulvihill, John J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA

Sharp, Richard R.
论文数: 0 引用数: 0
h-index: 0
机构:
Cleveland Clin, Dept Bioeth, Cleveland, OH 44106 USA Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA
[6]
What is the clinical utility of genetic testing?
[J].
Grosse, Scott D.
;
Khoury, Muin J.
.
GENETICS IN MEDICINE,
2006, 8 (07)
:448-450

Grosse, Scott D.
论文数: 0 引用数: 0
h-index: 0
机构: Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Coordinating Ctr Hlth Promot, Atlanta, GA 30333 USA

Khoury, Muin J.
论文数: 0 引用数: 0
h-index: 0
机构: Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Coordinating Ctr Hlth Promot, Atlanta, GA 30333 USA
[7]
Regulation of Laboratory-Developed Tests: The Case for Utilizing Professional Associations
[J].
Hockett, R. D.
;
Close, S. L.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2010, 88 (06)
:743-745

Hockett, R. D.
论文数: 0 引用数: 0
h-index: 0
机构:
Affymetrix Inc, Santa Clara, CA USA Affymetrix Inc, Santa Clara, CA USA

Close, S. L.
论文数: 0 引用数: 0
h-index: 0
机构:
Indiana Univ, Indianapolis, IN 46204 USA Affymetrix Inc, Santa Clara, CA USA
[8]
Evidence-Based Medicine in the Era of Biomarkers: Teaching a New Dog Old Tricks?
[J].
Holliday, E. G.
;
Scott, R. J.
;
Attia, J.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2010, 88 (06)
:740-742

Holliday, E. G.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2308, Australia Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia

Scott, R. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2308, Australia Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia

论文数: 引用数:
h-index:
机构:
[9]
Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice
[J].
Huang, S-M
;
Temple, R.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2008, 84 (03)
:287-294

Huang, S-M
论文数: 0 引用数: 0
h-index: 0
机构:
US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA

Temple, R.
论文数: 0 引用数: 0
h-index: 0
机构:
US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[10]
Personalized medicine: Elusive dream or imminent reality?
[J].
Lesko, L. J.
.
CLINICAL PHARMACOLOGY & THERAPEUTICS,
2007, 81 (06)
:807-816

Lesko, L. J.
论文数: 0 引用数: 0
h-index: 0
机构:
US FDA, Off Clin Pharmacol, Silver Spring, MD USA US FDA, Off Clin Pharmacol, Silver Spring, MD USA